Online Trial Tracker - Larvol Sigma

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Isentress (raltegravir) / Merck (MSD)

ACTRN12609000881235: A randomised open-label study comparing the safety and efficacy of ritonavir boosted lopinavir and 2-3 nucleoside reverse transcriptase inhibitors (NRTI) backbone versus ritonavir boosted lopinavir and raltegravir in participants virologically failing first-line non-nucleoside reverse transcriptase inhibitors (NNRTI)/2 NRTI therapy (the SECOND-LINE study). This study is for Human Immunodeficiency Virus (HIV) infection.

Active, not recruiting

550

University of New South Wales/Kirby Institute, University of New South Wales/Kirby Institute, Abbott, Merck Sharpe & Dohme, amfAR

Human Immunodeficiency Virus (HIV) -1 infection

2011-005270-35: Study of the effect of pregnancy on the concentrations of antiretroviral drugs in the blood of women with HIV infection Studio dell'effetto della gravidanza sulle concentrazioni dei farmaci antiretrovirali nel sangue di donne con infezione da HIV

Ongoing

120

Europe

Tablet, Capsule, soft, Capsule, hard, Film-coated tablet, VIRAMUNE*60CPR 200MG, COMBIVIR*FL 60CPR RIV, KALETRA*120CPR RIV 200MG+50MG, REYATAZ*60CPS 150MG, TRUVADA*30CPR RIV 200MG/245MG, PREZISTA*60CPR RIV 600MG, ISENTRESS*FL 60CPR RIV 400MG, NORVIR*FL 84CPS MOLLI 100MG

ISTITUTO NAZIONALE DELLE MALATTIE INFETTIVE LAZZARO SPALLANZANI, Istituto Superiore di Sanita'

HIV-1 infection Infezione da HIV-1, HIV infection Infezione da HIV, Diseases [C] - Virus Diseases [C02]

2014-003710-84: The CNS Integrase Inhibitor Study

Ongoing

Europe

Tivicay, Isentress, Truvada, Film-coated tablet, Tivicay, Isentress, Truvada

Imperial College London

Human Immunodificiency Virus, HIV, Diseases [C] - Virus Diseases [C02]

2015-000274-35: clinical trial to assess the safety, tolerability and efficacy of two dolutegravir-based simplification strategies in HIV-infected patients with prolonged virological suppression. ENSAYO CLÍNICO PARA EVALUAR LA SEGURIDAD, TOLERABILIDAD Y EFICACIA DE DOS ESTRATEGIAS DE SIMPLIFICACIÓN BASADAS EN DOLUTEGRAVIR EN PACIENTES INFECTADOS POR VIH CON SUPRESIÓN VIROLÓGICA SOSTENIDA.

Ongoing

450

Europe

Lamivudine, Efavirenz, nevirapine, J05AX12, Coated tablet, Capsule, hard, Tablet, Prolonged-release tablet, Tivicay, Stribild, TRUVADA, KIVEXA, ZIAGEN, VIREAD, EMTRIVA, ATRIPLA, EVIPLERA, ISENTRESS, RAYATAZ, PREZISTA, KALETRA, NORVIR, INTELENCE, EDURANT, TRIUMEQ

Fundació Lluita contra la SIDA, Fundació Lluita contra la SIDA

Infection with human immunodeficiency virus (HIV). Infección por el virus de la inmunodeficiencia humana (VIH)., HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]

2008-001611-38: Estudio piloto prospectivo de la farmacocinética y farmacodinamia de la interaciión entre tipranavir/ritonavir y raltegravir en pacientes infectados por el VIH-1

Ongoing

Europe

Isentress, Aptivus, Norvir, raltegravir, tipranavir, ritonavir, Isentress, Aptivus, Norvir, Isentress, Aptivus, Norvir

Jose M Gatell - Hospital Clinic de Barcelona

Pacientes con infección crónica por VIH-1

2009-013679-23: étude cas-témoins comparant l\'efficacité d’une combinaison thérapeutique contenant l\'inhibiteur de l\'intégrase raltégravir (400 mg x 2) ou une combinaison thérapeutique ne contenant pas le raltégravir sur la diminution de l\'ADN proviral chez des sujets prétraités présentant une infection par le VIH-1 avec une charge virale détectable

Ongoing

Europe

Raltegravir, J05AX08, Raltegravir, Raltegravir

STOP SIDA

Patients âgés de plus de 18 ans, infectés par le VIH et traités par Raltégravir.

2014-004578-40: SSAT 066 Renal Integrase Study

Not yet recruiting

Europe

Tivicay 50 mg film - coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets, Film-coated tablet, Tivicay 50 mg film-coated tablets, Isentress 400 mg Film-coated Tablets, Truvada 200 mg/245 mg film-coated tablets, Stribild 150 mg/150 mg/200 mg/245 mg film-coated tablets

St Stephen's AIDS Trust, Merck, Sharp & Dohme Limited

HIV

2016-000437-43: The time to protection and adherence requirements of Raltegravir with or without lamivudine in protection from HIV infection

Not yet recruiting

Europe

Raltegravir, Lamivudine, Tablet, Film-coated tablet, Raltegravir, Lamivudine

Guy's and St Thomas NHS Foundation Trust, Merck Sharp & Dhome Ltd

HIV, HIV, Diseases [C] - Virus Diseases [C02]

2017-004750-42: EFFICACY AND SAFETY OF A SIMPLIFICATION TREATMENT BASED ON DOLUTEGRAVIR AND DARUNAVIR / COBICISTAT VS USUAL TREATMENT IN SUPPRESSED HIV-1-INFECTED PATIENTS WITH MULTIDRUG RESISTANCE. Eficacia y seguridad de Dolutegravir más Darunavir/cobicistat como tratamiento de simplificación frente al tratamiento habitual en pacientes infectados por el VIH-1 virológicamente suprimidos y con resistencia a múltiples fármacos.

Ongoing

100

Europe

lamivudine, Efavirenz, Nevirapine, Film-coated tablet, Coated tablet, Capsule, hard, Tablet, Rezolsta, Tivicay, Ziagen, EMTRIVA, VIREAD, kivexa, Truvada, Intelence, Edurant, Atripla, Eviplera, Reyataz, Prezista, Kaletra, Norvir, Evotaz, Isentress, Stribild, Triumeq, Genvoya, Celsentri, Descovy

FUNDACIÓ LLUITA CONTRA LA SIDA, ViiV Healthcare

HIV-1 VIH-1, HIV infection Infección por VIH, Diseases [C] - Virus Diseases [C02]

2017-003470-14: Raltegravir One Thousand two hundred vs Darunavir-cb in Immnunosupressed Patients: ROTDIP Study Raltegravir 1200 versus Darunavir-cb en pacientes inmunodeprimidos: estudio ROTDIP

Not yet recruiting

Europe

Film-coated tablet, , ISENTRESS

FIMABIS Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud, APES Costa del Sol (Agencia Pública Empresarial Sanitaria Costa del Sol), MSD Merck Sharp & Dohme, MSD MErck Sharp & Dohme

Human Immunodeficiency Virus (HIV) infection Infección por el Virus de Inmunodeficiencia Humana (VIH), Human Immunodeficiency Virus (HIV) infection Infección por el Virus de Inmunodeficiencia Humana (VIH)., Diseases [C] - Virus Diseases [C02]

NCT04258475: The Influence of Concurrent Oral Calcium Carbonate Supplementation on Steady State Pharmacokinetics of Oral Raltegravir.

Recruiting

Canada

Raltegravir standard dosage of 1200 mg (two 600 mg tablets) orally once daily., RAL, Isentress®, Calcium carbonate antacid tablet, TUMS® Ultra Strength (US) 500 mg

Ottawa Hospital Research Institute

Calcium Supplementation in HIV Patients Using Raltegravir

06/24

01/25

PANNA-B PK, NCT05648201: Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers

Recruiting

Europe

Doravirine 100Mg Tab, pifeltro, Raltegravir 600Mg Tab, issentres, Biktarvy 50/200/25 Tab, biktarvy

Radboud University Medical Center, ZonMw: The Netherlands Organisation for Health Research and Development, Merck Sharp & Dohme LLC

Hiv

11/24

12/24

ACTRN12609000575235: Antiretroviral therapy intensification with raltegravir and/or hyper-immune bovine colostrum in Human Immunodeficiency Virus-1 (HIV-1) infected patients with suboptimal immunological response

Active, not recruiting

3/4

University of New South Wales (UNSW), National Centre in HIV Epidemiology and Clinical Research University of New South Wales (UNSW)

Human Immunodeficiency Virus (HIV)Infection



	Diseases Companies Products Productz Mechanisms of Action Sites